Why Galera Therapeutics (GRTX) Stock Is Nosediving
Why Galera Therapeutics (GRTX) Stock Is Nosediving
Galera Therapeutics Inc (NASDAQ:GRTX) shares are trading lower by 34.8% to $0.14 during Monday's session after the company received a notice from Nasdaq's Office of General Counsel stating that the Nasdaq Hearings Panel decided to delist the company's shares due to non-compliance with Nasdaq's continued listing standards.
Galera therapeutics公司（納斯達克代碼：GRTX）的股票在週一交易時下跌了34.8％，至0.14美元，因爲該公司收到了納斯達克總法律顧問辦公室的通知，稱納斯達克聽證會決定將公司股票從納斯達克股票市場除牌，因爲公司未能符合納斯達克股票市場的繼續上市標準。
The company failed to meet the minimum average market value of listed securities, the minimum bid price, and the minimum market value of publicly held shares. As a result, trading of the company's shares will be suspended on Nasdaq starting June 4, 2024.
該公司未達到上市證券最低平均市值、最低買入價和公開持股市值最低標準。因此，該公司的股票交易將從2024年6月4日起在納斯達克停牌。
Galera Therapeutics plans for its shares to be quoted on the OTC Markets Group under the symbol "GRTX" following the suspension. The company says it retains the right to request a review of the delisting decision.
隨着停牌，Galera therapeutics計劃在場外市場集團（OTC Markets Group）通過標的爲“GRTX”的名稱引用其股票。該公司表示，保留請求審查除牌決定的權利。
According to data from Benzinga Pro, GRTX has a 52-week high of $3.59 and a 52-week low of $0.08.
根據Benzinga Pro的數據，GRTX股票52周最高價爲$3.59，52周最低價爲$0.08。
譯文內容由第三人軟體翻譯。